189.68

0.51% -0.97

Repligen Corp (RGEN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RGEN Giù? Forum Previsione

Precedente Chiudi:

$190.65

Aprire:

$189.92

Volume 24 ore:

1.50M

Relative Volume:

1.33

Capitalizzazione di mercato:

$10.70B

Reddito:

$763.34M

Utile/perdita netta:

$51.40M

Rapporto P/E:

208.81

EPS:

0.9084

Flusso di cassa netto:

$104.46M

1 W Prestazione:

+7.23%

1M Prestazione:

+4.40%

6M Prestazione:

+65.92%

1 anno Prestazione:

+55.88%

Intervallo 1D:

$186.91

$191.51

Intervallo di 1 settimana:

$176.22

$192.49

Portata 52W:

$100.99

$192.49

Repligen Corp Stock (RGEN) Company Profile

Nome

Repligen Corp

Settore

Healthcare (1067)

Industria

Medical Instruments & Supplies (56)

Telefono

(781) 449-9560

Indirizzo

41 SEYON STREET, WALTHAM, MA

Dipendente

2,000

Cinguettio

@repligen

Prossima data di guadagno

2026-10-27

Ultimi documenti SEC

RGEN's Discussions on Twitter

Compare RGEN vs ISRG, BDX, RMD, ALC, MDLN

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
RGEN Repligen Corp	189.68	10.70B	763.34M	51.40M	104.46M	0.9084
ISRG Intuitive Surgical Inc	405.18	143.14B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	183.82	50.07B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	222.00	32.02B	5.54B	1.52B	1.74B	10.37
ALC Alcon Inc	64.47	31.16B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	34.70	30.44B	29.14B	1.07B	1.05B	1.1956

Repligen Corp Stock (RGEN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-09-09	Ripresa	UBS	Buy
2026-07-07	Aggiornamento	The Benchmark Company	Hold → Buy
2026-06-02	Ripresa	Wolfe Research	Outperform
2026-05-15	Ripresa	RBC Capital Mkts	Outperform
2026-04-17	Iniziato	Rothschild & Co Redburn	Buy
2025-10-01	Iniziato	HSBC Securities	Buy
2025-09-22	Aggiornamento	Evercore ISI	In-line → Outperform
2025-07-22	Ripresa	Stephens	Overweight
2025-06-24	Iniziato	Barclays	Overweight
2025-04-29	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2025-03-18	Iniziato	Evercore ISI	In-line
2025-02-10	Iniziato	TD Cowen	Buy
2024-12-17	Iniziato	Canaccord Genuity	Hold
2024-11-14	Iniziato	Wolfe Research	Peer Perform
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-06-26	Aggiornamento	Deutsche Bank	Hold → Buy
2024-06-18	Iniziato	Guggenheim	Neutral
2023-12-04	Downgrade	The Benchmark Company	Buy → Hold
2023-07-20	Iniziato	Wells Fargo	Overweight
2023-07-05	Ripresa	JP Morgan	Overweight
2023-03-28	Iniziato	The Benchmark Company	Buy
2022-12-14	Iniziato	Deutsche Bank	Hold
2022-12-07	Iniziato	RBC Capital Mkts	Sector Perform
2022-07-20	Iniziato	UBS	Buy
2021-10-14	Iniziato	Exane BNP Paribas	Outperform
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-08-24	Reiterato	H.C. Wainwright	Buy
2020-06-30	Reiterato	H.C. Wainwright	Buy
2020-05-07	Reiterato	H.C. Wainwright	Buy
2020-03-23	Reiterato	H.C. Wainwright	Buy
2019-11-15	Iniziato	Stifel	Buy
2019-11-01	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2019-10-15	Iniziato	SVB Leerink	Outperform
2019-08-28	Reiterato	First Analysis Sec	Outperform
2019-08-23	Ripresa	Stephens	Overweight
2019-07-22	Aggiornamento	H.C. Wainwright	Neutral → Buy
2018-12-17	Aggiornamento	CL King	Neutral → Buy
2018-11-12	Downgrade	CL King	Buy → Neutral
2018-09-26	Iniziato	H.C. Wainwright	Neutral
2017-12-08	Iniziato	Citigroup	Buy
2017-12-05	Iniziato	JP Morgan	Overweight
2017-11-13	Iniziato	CL King	Buy
2017-10-02	Aggiornamento	First Analysis Sec	Equal-Weight → Overweight
2017-07-21	Iniziato	William Blair	Outperform
2017-02-13	Aggiornamento	Piper Jaffray	Neutral → Overweight

Mostra tutto

Repligen Corp Borsa (RGEN) Ultime notizie

03:54 AM

Form 4 Repligen Corporation For: 26 September By Investing.com - Investing.com India

03:54 AM

02:27 AM

Repligen CEO Loeillot sells $2.46m in shares - Investing.com

02:27 AM

02:11 AM

Repligen CEO Loeillot sells $2.46m in shares By Investing.com - Investing.com Australia

02:11 AM

Sep 25, 2026